The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)
- 1 October 2000
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 111 (1), 78-90
- https://doi.org/10.1046/j.1365-2141.2000.02327.x
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Prevalence of factor IX inhibitors among patients with haemophilia B: results of a large‐scale North American surveyHaemophilia, 1996
- DDAVP in acquired hemophilia a: Case report and review of the literatureAmerican Journal of Hematology, 1993
- Comparison of Anti-Human and Anti-Porcine Factor VIII Inhibitor Levels in 63 Patients with Severe Haemophilia AVox Sanguinis, 1993
- The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experienceArchives of Internal Medicine, 1989
- Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII:C inhibitorPublished by Oxford University Press (OUP) ,1989
- Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIIINew England Journal of Medicine, 1988
- Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapyArchives of Internal Medicine, 1987
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- Corticosteroid Therapy for Acquired F VIII:C InhibitorsBritish Journal of Haematology, 1981
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIINew England Journal of Medicine, 1980